Maintenance Infos

Browse by Creators

Navigate back| Up a level
Export as
Number of items: 65.

Cronin, A; Decker, M; Arand, M (2011). Mammalian soluble epoxide hydrolase is identical to liver hepoxilin hydrolase. Journal of Lipid Research, 52(4):712-719.

Christen, V; Caminada, D; Arand, M; Fent, K (2010). Identification of a CYP3A form (CYP3A126) in fathead minnow (Pimephales promelas) and characterisation of putative CYP3A enzyme activity. Analytical and Bioanalytical Chemistry, 396(2):585-595.

Marowsky, A; Cronin, A; Frère, F; Adamska, M; Arand, M (2010). Mammalian Epoxide Hydrolases. In: Elsevier. Comprehensive Toxicology. Amsterdam: Elsevier, 275-294.

Marowsky, A; Burgener, J; Falck, J R; Fritschy, J M; Arand, M (2009). Distribution of soluble and microsomal epoxide hydrolase in the mouse brain and its contribution to cerebral epoxyeicosatrienoic acid metabolism. Neuroscience, 163(2):646-661.

Reetz, M T; Bocola, M; Wang, L W; Sanchis, J; Cronin, A; Arand, M; Zou, J; Archelas, A; Bottalla, A L; Naworyta, A; Mowbray, S L (2009). Directed evolution of an enantioselective epoxide hydrolase: uncovering the source of enantioselectivity at each evolutionary stage. Journal of the American Chemical Society, 131(21):7334-43.

Deckert, M; Arand, M; Cronin, A (2009). Mammalian epoxide hydrolases in xenobiotic metabolism and signalling. Archives of Toxicology, 83(4):297-318.

Bodenmann, S; Xu, S; Luhmann, U; Arand, M; Berger, W; Jung, H; Landolt, H P (2009). Pharmacogenetics of Modafinil after sleep loss: Catechol-O-methyltransferase genotype modulates waking functions but not recovery sleep. Clinical Pharmacology and Therapeutics, 85(3):296-304.

Stieger, B; Arand, M (2009). Biotransformation und Detoxifizierung in der Leber. In: Schartl, M; Gessler, M; von Eckardstein, A. Biochemie und Molekularbiologie des Menschen. München: Urban und Fischer, 845-859.

Harris, T R; Aronov, A; Jones, P D; Tanaka, H; Arand, M; Hammock, B D (2008). Identification of two epoxide hydrolases in Caenorhabditis elegans that metabolize mammalian lipid signaling molecules. Archives of Biochemistry and Biophysics, 472(2):139-149.

Cronin, A; Homburg, S; Dürk, H; Richter, I; Adamska, M; Frère, F; Arand, M (2008). Insights into the catalytic mechanism of human sEH phosphatase by site-directed mutagenesis and LC-MS/MS analysis. Journal of Molecular Biology, 383(3):627-640.

Oesch-Bartlomowicz, B; Huelster, A; Wiss, O; Antoniou-Lipfert, P; Dietrich, C; Arand, M; Weiss, C; Bockamp, E; Oesch, F (2005). Aryl hydrocarbon receptor activation by cAMP vs. dioxin: divergent signaling pathways. Proceedings of the National Academy of Sciences of the United States of America (PNAS), 102(26):9218-9223.

Rojas, A L; Nagem, R A P; Neustroev, K N; Arand, M; Adamska, M; Eneyskaya, E V; Kulminskaya, A A; Garratt, R C; Golubev, A M; Polikarpov, I (2004). Crystal structures of beta-galactosidase from Penicillium sp. and its complex with galactose. Journal of Molecular Biology, 343(5):1281-1292.

Ringhoffer, M; Schmitt, M; Karbach, J; Jäger, E; Oesch, F; Arand, M (2001). Quantitative assessment of the expression of melanoma-associated antigens by non-competitive reverse transcription polymerase chain reaction. International Journal of Oncology, 19(5):983-989.

Härtter, S; Wang, X; Weigmann, H; Friedberg, T; Arand, M; Oesch, F; Hiemke, C (2001). Differential effects of fluvoxamine and other antidepressants on the biotransformation of melatonin. Journal of Clinical Psychopharmacology, 21(2):167-174.

Jäger, E; Gnjatic, S; Nagata, Y; Stockert, E; Jäger, D; Karbach, J; Neumann, A; Rieckenberg, J; Chen, Y T; Ritter, G; Hoffman, E; Arand, M; Old, L J; Knuth, A (2000). Induction of primary NY-ESO-1 immunity: CD8+ T lymphocyte and antibody responses in peptide-vaccinated patients with NY-ESO-1+ cancers. Proceedings of the National Academy of Sciences of the United States of America, 97(22):12198-12203.

Jäger, E; Nagata, Y; Gnjatic, S; Wada, H; Stockert, E; Karbach, J; Dunbar, P R; Lee, S Y; Jungbluth, A; Jäger, D; Arand, M; Ritter, G; Cerundolo, V; Dupont, B; Chen, Y T; Old, L J; Knuth, A (2000). Monitoring CD8 T cell responses to NY-ESO-1: correlation of humoral and cellular immune responses. Proceedings of the National Academy of Sciences of the United States of America, 97(9):4760-4765.

Kessler, R; Hamou, M F; Albertoni, M; de Tribolet, N; Arand, M; Van Meir, E G (2000). Identification of the putative brain tumor antigen BF7/GE2 as the (de)toxifying enzyme microsomal epoxide hydrolase. Cancer Research, 60(5):1403-1409.

Jäger, E; Jäger, D; Karbach, J; Chen, Y T; Ritter, G; Nagata, Y; Gnjatic, S; Stockert, E; Arand, M; Old, L J; Knuth, A (2000). Identification of NY-ESO-1 epitopes presented by human histocompatibility antigen (HLA)-DRB4*0101-0103 and recognized by CD4(+) T lymphocytes of patients with NY-ESO-1-expressing melanoma. Journal of Experimental Medicine, 191(4):625-630.

Zou, J; Hallberg, B M; Bergfors, T; Oesch, F; Arand, M; Mowbray, S L; Jones, T A (2000). Structure of Aspergillus niger epoxide hydrolase at 1.8 A resolution: implications for the structure and function of the mammalian microsomal class of epoxide hydrolases. Structure, 8(2):111-22.

Oesch, F; Herrero, M E; Hengstler, J G; Lohmann, M; Arand, M (2000). Metabolic detoxification: implications for thresholds. Toxicologic pathology, 28(3):382-387.

Steinberg, P; Fischer, T; Arand, M; Park, E; Elmadfa, I; Rimkus, G; Brunn, H; Dienes, H P (1999). Acute hepatotoxicity of the polycyclic musk 7-acetyl-1,1,3,4,4,6-hexamethyl-1,2,3,4-tetrahydronaphtaline (AHTN). Toxicology Letters, 111(1-2):151-160.

Arand, M; Hemmer, H; Dürk, H; Baratti, J; Archelas, A; Furstoss, R; Oesch, F (1999). Cloning and molecular characterization of a soluble epoxide hydrolase from Aspergillus niger that is related to mammalian microsomal epoxide hydrolase. Biochemical Journal, 344 Pt 1:273-280.

Jäger, E; Stockert, E; Zidianakis, Z; Chen, Y T; Karbach, J; Jäger, D; Arand, M; Ritter, G; Old, L J; Knuth, A (1999). Humoral immune responses of cancer patients against "Cancer-Testis" antigen NY-ESO-1: correlation with clinical events. International Journal of Cancer, 84(5):506-510.

Hengstler, J G; Lange, J; Kett, A; Dornhöfer, N; Meinert, R; Arand, M; Knapstein, P G; Becker, R; Oesch, F; Tanner, B (1999). Contribution of c-erbB-2 and topoisomerase IIalpha to chemoresistance in ovarian cancer. Cancer Research, 59(13):3206-3214.

Poppe, M; Hahm, B; Eickelbaum, W; Arand, M; Paweletz, N; Knehr, M (1999). Use of PCR to screen for promoter elements in genomic DNA library clones. BioTechniques, 26(4):718-22, 724.

Mullen, R T; Trelease, R N; Duerk, H; Arand, M; Hammock, B D; Oesch, F; Grant, D F (1999). Differential subcellular localization of endogenous and transfected soluble epoxide hydrolase in mammalian cells: evidence for isozyme variants. FEBS letters, 445(2-3):301-305.

Arand, M; Müller, F; Mecky, A; Hinz, W; Urban, P; Pompon, D; Kellner, R; Oesch, F (1999). Catalytic triad of microsomal epoxide hydrolase: replacement of Glu404 with Asp leads to a strongly increased turnover rate. Biochemical Journal, 337 ( Pt:37-43.

Hengstler, J G; Kett, A; Arand, M; Oesch-Bartlomowicz, B; Oesch, F; Pilch, H; Tanner, B (1998). Glutathione S-transferase T1 and M1 gene defects in ovarian carcinoma. Cancer Letters, 130(1-2):43-48.

Stockert, E; Jäger, E; Chen, Y T; Scanlan, M J; Gout, I; Karbach, J; Arand, M; Knuth, A; Old, L J (1998). A survey of the humoral immune response of cancer patients to a panel of human tumor antigens. Journal of Experimental Medicine, 187(8):1349-1354.

Jäger, E; Chen, Y T; Drijfhout, J W; Karbach, J; Ringhoffer, M; Jäger, D; Arand, M; Wada, H; Noguchi, Y; Stockert, E; Old, L J; Knuth, A (1998). Simultaneous humoral and cellular immune response against cancer-testis antigen NY-ESO-1: definition of human histocompatibility leukocyte antigen (HLA)-A2-binding peptide epitopes. Journal of Experimental Medicine, 187(2):265-270.

Tanner, B; Hengstler, J G; Luch, A; Meinert, R; Kreutz, E; Arand, M; Wilkens, C; Hofmann, M; Oesch, F; Knapstein, P G; Becker, R (1998). C-myc mRNA expression in epithelial ovarian carcinomas in relation to estrogen receptor status, metastatic spread, survival time, FIGO stage, and histologic grade and type. International Journal of Gynecological Pathology, 17(1):66-74.

Müller, F; Arand, M; Frank, H; Seidel, A; Hinz, W; Winkler, L; Hänel, K; Blée, E; Beetham, J K; Hammock, B D; Oesch, F (1997). Visualization of a covalent intermediate between microsomal epoxide hydrolase, but not cholesterol epoxide hydrolase, and their substrates. European Journal of Biochemistry, 245(2):490-496.

Jäger, E; Ringhoffer, M; Altmannsberger, M; Arand, M; Karbach, J; Jäger, D; Oesch, F; Knuth, A (1997). Immunoselection in vivo: independent loss of MHC class I and melanocyte differentiation antigen expression in metastatic melanoma. International Journal of Cancer, 71(2):142-147.

Herrero, M E; Arand, M; Hengstler, J G; Oesch, F (1997). Recombinant expression of human microsomal epoxide hydrolase protects V79 Chinese hamster cells from styrene oxide- but not from ethylene oxide-induced DNA strand breaks. Environmental and Molecular Mutagenesis, 30(4):429-439.

Jäger, E; Ringhoffer, M; Arand, M; Karbach, J; Jäger, D; Ilsemann, C; Hagedorn, M; Oesch, F; Knuth, A (1996). Cytolytic T cell reactivity against melanoma-associated differentiation antigens in peripheral blood of melanoma patients and healthy individuals. Melanoma research, 6(6):419-425.

Friedberg, T; Holler, R; Löllmann, B; Arand, M; Oesch, F (1996). The catalytic activity of the endoplasmic reticulum-resident protein microsomal epoxide hydrolase towards carcinogens is retained on inversion of its membrane topology. Biochemical Journal, 319:131-136.

Knehr, M; Poppe, M; Schroeter, D; Eickelbaum, W; Finze, E M; Kiesewetter, U L; Enulescu, M; Arand, M; Paweletz, N (1996). Cellular expression of human centromere protein C demonstrates a cyclic behavior with highest abundance in the G1 phase. Proceedings of the National Academy of Sciences of the United States of America, 93(19):10234-10239.

Jäger, E; Ringhoffer, M; Dienes, H P; Arand, M; Karbach, J; Jäger, D; Ilsemann, C; Hagedorn, M; Oesch, F; Knuth, A (1996). Granulocyte-macrophage-colony-stimulating factor enhances immune responses to melanoma-associated peptides in vivo. International Journal of Cancer, 67(1):54-62.

Oesch, F; Arand, M; Benedetti, M S; Castelli, M G; Dostert, P (1996). Inducing properties of rifampicin and rifabutin for selected enzyme activities of the cytochrome P-450 and UDP-glucuronosyltransferase superfamilies in female rat liver. Journal of Antimicrobial Chemotherapy, 37(6):1111-1119.

Jäger, E; Ringhoffer, M; Karbach, J; Arand, M; Oesch, F; Knuth, A (1996). Inverse relationship of melanocyte differentiation antigen expression in melanoma tissues and CD8+ cytotoxic-T-cell responses: evidence for immunoselection of antigen-loss variants in vivo. International Journal of Cancer, 66(4):470-476.

Jäeger, E; Bernhard, H; Romero, P; Ringhoffer, M; Arand, M; Karbach, J; Ilsemann, C; Hagedorn, M; Knuth, A (1996). Generation of cytotoxic T-cell responses with synthetic melanoma-associated peptides in vivo: implications for tumor vaccines with melanoma-associated antigens. International Journal of Cancer, 66(2):162-169.

Arand, M; Mühlbauer, R; Hengstler, J; Jäger, E; Fuchs, J; Winkler, L; Oesch, F (1996). A multiplex polymerase chain reaction protocol for the simultaneous analysis of the glutathione S-transferase GSTM1 and GSTT1 polymorphisms. Analytical Biochemistry, 236(1):184-186.

Arand, M; Wagner, H; Oesch, F (1996). Asp333, Asp495, and His523 form the catalytic triad of rat soluble epoxide hydrolase. Journal of Biological Chemistry, 271(8):4223-4229.

Fändrich, F; Degiuli, B; Vogel-Bindel, U; Arand, M; Oesch, F (1995). Induction of rat liver microsomal epoxide hydrolase by its endogenous substrate 16 alpha, 17 alpha-epoxyestra-1,3,5-trien-3-ol. Xenobiotica; the fate of foreign compounds in biological systems, 25(3):239-244.

Beetham, J K; Grant, D; Arand, M; Garbarino, J; Kiyosue, T; Pinot, F; Oesch, F; Belknap, W R; Shinozaki, K; Hammock, B D (1995). Gene evolution of epoxide hydrolases and recommended nomenclature. DNA and cell biology, 14(1):61-71.

Härtter, S; Arand, M; Oesch, F; Hiemke, C (1995). Non-competitive inhibition of clomipramine N-demethylation by fluvoxamine. Psychopharmacology, 117(2):149-153.

Diener, B; Abdel-Latif, H; Arand, M; Oesch, F (1995). Xenobiotic metabolizing enzyme activities and viability are well preserved in EDTA-isolated rat liver parenchymal cells after cryopreservation. Toxicology and applied pharmacology, 130(1):149-153.

Oesch, F; Hengstler, J G; Arand, M; Fuchs, J (1995). Detection of primary DNA damage: applicability to biomonitoring of genotoxic occupational exposure and in clinical therapy. Pharmacogenetics, 5 Spec N:S118-S122.

Diener, B; Traiser, M; Arand, M; Leissner, J; Witsch, U; Hohenfellner, R; Fändrich, F; Vogel, I; Utesch, D; Oesch, F (1994). Xenobiotic metabolizing enzyme activities in isolated and cryopreserved human liver parenchymal cells. Toxicology in Vitro, 8(6):1161-1166.

Strolin Benedetti, M S; Marrari, P; Colombo, M; Castelli, M G; Arand, M; Oesch, F; Dostert, P (1994). The anticonvulsant FCE 26743 is a selective and short-acting MAO-B inhibitor devoid of inducing properties towards cytochrome P450-dependent testosterone hydroxylation in mice and rats. Journal of Pharmacy and Pharmacology, 46(10):814-819.

Arand, M; Grant, D F; Beetham, J K; Friedberg, T; Oesch, F; Hammock, B D (1994). Sequence similarity of mammalian epoxide hydrolases to the bacterial haloalkane dehalogenase and other related proteins. Implication for the potential catalytic mechanism of enzymatic epoxide hydrolysis. FEBS letters, 338(3):251-256.

Knehr, M; Thomas, H; Arand, M; Gebel, T; Zeller, H D; Oesch, F (1993). Isolation and characterization of a cDNA encoding rat liver cytosolic epoxide hydrolase and its functional expression in Escherichia coli. Journal of Biological Chemistry, 268(23):17623-17627.

Utesch, D; Arand, M; Thomas, H; Petzinger, E; Oesch, F (1992). Xenobiotic-metabolizing enzyme activities in hybrid cell lines established by fusion of primary rat liver parenchymal cells with hepatoma cells. Xenobiotica; the fate of foreign compounds in biological systems, 22(12):1451-1457.

Arand, M; Friedberg, T; Oesch, F (1992). Colorimetric quantitation of trace amounts of sodium lauryl sulfate in the presence of nucleic acids and proteins. Analytical Biochemistry, 207(1):73-75.

Oesch, F; Wagner, H; Platt, K L; Arand, M (1992). Improved sample preparation for the testosterone hydroxylation assay using disposable extraction columns. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 582(1-2):232-235.

Friedberg, T; Grassow, M A; Bartlomowicz-Oesch, B; Siegert, P; Arand, M; Adesnik, M; Oesch, F (1992). Sequence of a novel cytochrome CYP2B cDNA coding for a protein which is expressed in a sebaceous gland, but not in the liver. Biochemical Journal, 287:775-783.

Gebel, T; Arand, M; Oesch, F (1992). Induction of the peroxisome proliferator activated receptor by fenofibrate in rat liver. FEBS letters, 309(1):37-40.

Oesch, F; Arand, M; Coughtrie, M W; Burchell, B; Steinberg, P (1992). The distribution of UDP-glucuronosyltransferases in rat liver parenchymal and nonparenchymal cells. Biochemical Pharmacology, 43(4):731-737.

Arand, M; Knehr, M; Thomas, H; Zeller, H D; Oesch, F (1991). An impaired peroxisomal targeting sequence leading to an unusual bicompartmental distribution of cytosolic epoxide hydrolase. FEBS letters, 294(1-2):19-22.

Arand, M; Coughtrie, M W; Burchell, B; Oesch, F; Robertson, L W (1991). Selective induction of bilirubin UDP-glucuronosyl-transferase by perfluorodecanoic acid. Chemico-biological interactions, 77(1):97-105.

Oesch, F; Arand, M (1989). Molecular aspects of carcinogenesis. Part B. Journal of Cancer Research and Clinical Oncology, 115(6):606-607.

Arand, M; Robertson, L W; Oesch, F (1987). A fluorometric assay for quantitating phenol sulfotransferase activities in homogenates of cells and tissues. Analytical Biochemistry, 163(2):546-551.

Azais, V; Arand, M; Rauch, P; Schramm, H; Bellenand, P; Narbonne, J F; Oesch, F; Pascal, G; Robertson, L W (1987). A time-course investigation of vitamin A levels and drug metabolizing enzyme activities in rats following a single treatment with prototypic polychlorinated biphenyls and DDT. Toxicology, 44(3):341-354.

Glatt, H R; Robertson, L W; Arand, M; Rauch, P; Schramm, H; Setiabudi, F; Pöchlauer, P; Müller, E P; Oesch, F (1986). cis- and trans-1,2-diphenylaziridines: induction of xenobiotic-metabolizing enzymes in rat liver and mutagenicity in Salmonella typhimurium. Archives of toxicology, 59(4):242-248.

Azais, V; Pascal, G; Arand, M; Oesch, F; Robertson, L W (1986). Effects of congeneric polychlorinated biphenyls on liver and kidney retinoid levels. Chemosphere, 15(9-12):1905-1908.

This list was generated on Thu Jun 20 09:55:00 2019 CEST.